SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-070381
Filing Date
2020-03-11
Accepted
2020-03-11 16:41:40
Documents
5
Effectiveness Date
2020-03-11

Document Format Files

Seq Description Document Type Size
1 S-8 d903333ds8.htm S-8 59398
2 EX-5.1 d903333dex51.htm EX-5.1 7755
3 EX-23.1 d903333dex231.htm EX-23.1 2406
4 GRAPHIC g903333g0311050744522.jpg GRAPHIC 2598
5 GRAPHIC g903333g0311050744835.jpg GRAPHIC 2534
  Complete submission text file 0001193125-20-070381.txt   77958
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237089 | Film No.: 20705800
SIC: 2834 Pharmaceutical Preparations